Pioneering Drug Discovery and Development

Proprietary positions in the regulation of cellular chronological lifespan allow Chronos Therapeutics’ research to be successfully advanced into pre-clinical stages of development for age-related disease treatments.

Focussed Drug Development

Chronos Therapeutics’ drug development scheme focuses in two main areas:

• Repositioning FDA approved drugs.
• Screening, discovery and development of novel proprietary drug candidates.

Current Targets

• Diseases of Ageing: Osteoporosis, Cancer and Sarcopenia.
• Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, ALS and Orphan Synucleopathies.